ADAMTS 13 (VON WILLEBRAND FACTOR CLEAVING PROTEASE) - ANVISA Registration 81816720024

Access comprehensive regulatory information for ADAMTS 13 (VON WILLEBRAND FACTOR CLEAVING PROTEASE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81816720024 and manufactured by TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH, TECHNOCLONE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.